Ligand · 6ZG
6ZG · ~{N}'-[7-(4-methylphenyl)pyrido[3,4-b]pyrazin-5-yl]butane-1,4-diamine
6ZG, ~{N}'-[7-(4-methylphenyl)pyrido[3,4-b]pyrazin-5-yl]butane-1,4-diamine (C18 H21 N5, 307.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å, the residues…
- Component
- 6ZG
- Formula
- C18 H21 N5
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
6ZG in 2 structures; the first of them:
- 5LMA · Human spleen tyrosine kinase kinase domain in complex with azanaphthyridine inhibitor · 6ZG A701 · binds LEU377, GLY378, VAL385, ALA400, VAL433, MET448, GLU449, MET450 and 10 more
- 5LMA · Human spleen tyrosine kinase kinase domain in complex with azanaphthyridine inhibitor · 6ZG A701 · binds LEU377, GLY378, VAL385, ALA400, GLU449, MET450, ALA451, GLU452 and 7 more
Residues it binds most
LEU 2, ALA 2, GLU 2, GLY 2, MET 2, VAL 2, ARG 2, ASN 2, ASP 2, PRO 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.